Nonsedating antihistamines in the treatment of severe chronic idiopathic urticaria: are they used optimally?

被引：1

作者：

Cheung, ST ^{[1
]}

Tucker, W ^{[1
]}

机构：

[1] Worcestershire Royal Hosp, Dept Dermatol, Worcester, England

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2006年 / 154卷 / 05期

关键词：

D O I：

10.1111/j.1365-2133.2006.07207.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：1012 / 1013

页数：3

共 15 条

[1] Oral cyclophosphamide in a case of cyclosporin and steroid-resistant chronic urticaria showing autoreactivity on autologous serum skin testing [J].

Asero, R .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2005, 30 (05) :582-583

[2] URTICARIA AND ANGIO-OEDEMA - A REVIEW OF 554 PATIENTS [J].

CHAMPION, RH ;

ROBERTS, SOB ;

CARPENTER, RG ;

ROGER, JH .

BRITISH JOURNAL OF DERMATOLOGY, 1969, 81 (08) :588-+

[3] Chronic urticaria responding to subcutaneous heparin sodium [J].

Chua, SL ;

Gibbs, S .

BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (01) :216-217

[4] Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997 [J].

Craig-McFeely, PM ;

Acharya, NV ;

Shakir, SAW .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (04) :313-320

[5] Management and diagnostic guidelines for urticaria and angio-oedema [J].

Grattan, C ;

Powell, S ;

Humphreys, A .

BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (04) :708-714

[6] Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis [J].

Hampel, F ;

Ratner, P ;

Mansfield, L ;

Meeves, S ;

Liao, YN ;

Georges, G .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2003, 91 (04) :354-361

[7] Chronic urticaria - Aetiology, management and current and future treatment options [J].

Kozel, MMA ;

Sabroe, RA .

DRUGS, 2004, 64 (22) :2515-2536

[8] Deslorataidine - An update of its efficacy in the management of allergic disorders [J].

Murdoch, D ;

Goa, KL ;

Keam, SJ .

DRUGS, 2003, 63 (19) :2051-2077

[9] Qi lengthening and life-threatening arrhythmias associated with fexofenadine [J].

Pinto, YM ;

van Gelder, IC ;

Heeringa, M ;

Crijns, HJGM .

LANCET, 1999, 353 (9157) :980-980

[10] Cardiovascular safely of fexofenadine HCl [J].

Pratt, CM ;

Mason, J ;

Russell, T ;

Reynolds, R ;

Ahlbrandt, R .

AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (10) :1451-1454

← 1 2 →